Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
Development of new ricin A-chain immunotoxins with potent anti-tumor effects against human Hodgkin cells in vitro and disseminated Hodgkin tumors in SCID mice using high-affinity monoclonal antibodies directed against the CD30 antigen.
Int J Cancer. 1995 Oct 9;63(2):238-44. doi: 10.1002/ijc.2910630216.
Int J Cancer. 1995.
PMID: 7591211
Shedding of the soluble form of CD30 from the Hodgkin-analogous cell line L540 is strongly inhibited by a new CD30-specific antibody (Ki-4).
Horn-Lohrens O, Tiemann M, Lange H, Kobarg J, Hafner M, Hansen H, Sterry W, Parwaresch RM, Lemke H.
Horn-Lohrens O, et al.
Int J Cancer. 1995 Feb 8;60(4):539-44. doi: 10.1002/ijc.2910600419.
Int J Cancer. 1995.
PMID: 7530238
Item in Clipboard
A zinc metalloproteinase is responsible for the release of CD30 on human tumor cell lines.
Hansen HP, Kisseleva T, Kobarg J, Horn-Lohrens O, Havsteen B, Lemke H.
Hansen HP, et al. Among authors: horn lohrens o.
Int J Cancer. 1995 Nov 27;63(5):750-6. doi: 10.1002/ijc.2910630524.
Int J Cancer. 1995.
PMID: 7591296
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.